Life Scientist > Lab Technology

Beattie announces $473m funding boost

19 April, 2005 by Graeme O'Neill

Queensland's Beattie Government has announced AUD$473 million in new funding for the second phase of its Smart State Strategy.


Invest in basic science to reap rewards: expert

14 April, 2005 by Staff Writers

Mark Crowell -- a leading US technology-transfer expert -- has a message for Australian universities wanting to make money out of research: it is vital that the public sector continue funding good, basic science to drive the knowledge economy.


Vic govt announces $57m in infrastructure grants

14 April, 2005 by Renate Krelle

A tissue engineering centre, a tumour tissue banking facility and a biopharmaceutical formulation facility are three of 17 projects that will share a total of $57 million in major infrastructure grants, announced today by the Victorian government.


Australians publishing more, but not patenting: report

13 April, 2005 by Renate Krelle

Although government and higher education R&D expenditure are on the up, and Australia generated almost 50 per cent more scientific and technical articles in 2003 than in 1999, the number of US patents granted to Australia has fallen, a government report has revealed.


Database access helps protect privacy: Stanley

13 April, 2005 by Susan Williamson

Western Australia's well-established record-linked healthcare database had been an important innovation for research, but had also helped to better awareness of privacy issues, according to Prof Fiona Stanley, director of the Telethon Institute for Child Health Research in Perth.


In brief: AustCancer; Life Therapeutics; Amrad; Genesis Research; Avastra

13 April, 2005 by Staff Writers

Australian Cancer Technology (ASX:ACU) has announced a 1:3 non-renounceable entitlements issue, aiming to raise $5.7 million at $0.13 per share. Shares in the company were trading at $0.17 at time of writing.


Sydney firm Apollo aims for sweet lift-off

08 April, 2005 by Graeme O'Neill

Do you want sugars with that? Sydney protein specialist Apollo is planning an IPO next month to raise funds to develop its extensive portfolio of glycosylated proteins as research agents and therapeutics.


Making strange or making sense - art and the life sciences

07 April, 2005 by Oron Catts and Ionat Zurr

Oron Catts and Ionat Zurr talk about the future with Bioart.


In brief: Benitec, XRT, Phylogica, Norwood Abbey

06 April, 2005 by Staff Writers

RNAi specialist Benitec (ASX:BLT) has lodged a prospectus with ASIC to raise up to AUD$9.7 million in a rights issue, underwritten by Bell Potter. Capital raised will go towards clinical development and expansion of Benitec's California operations, it said.


Research prospective

05 April, 2005 by Nigel Poole

Nigel Poole offers 10 glimpses of what Australian life science commercialisation could look like in 2015.


Can life sciences go the IT way?

05 April, 2005 by Prashant Tyagi

The life sciences can learn from the IT revolution, Prashant Tyagi explains.


Legal Challenges

05 April, 2005 by Trevor Davies

With technology advancing so rapidly in many potential commercial areas of life science, patent attorneys, intellectual property (IP) and commercial lawyers, and lawmakers will face a number of challenges over the next 10 years, says Trevor Davies.


In brief: changes at Psiron, ATPi, Cytopia, Epitan

04 April, 2005 by Renate Krelle

Psiron (ASX:PSX) has announced that Stephen Jones will assume day-to-day control of the company, taking on the role of executive chairman. Julie Nutting will continue as the company's chief executive with responsibility for five clinical trial and manufacturing milestones for the company's CVA 21 virus by the end of the year.


Biotech students band together

01 April, 2005 by Melissa Trudinger

The South Australian branch of the AusBiotech Student Association (ABSA) was launched last night in Adelaide.


In brief: Resonance Health; Covance

24 March, 2005 by Staff Writers

Australia's largest diagnostic imaging company, DCA Group (ASX: DVC) has agreed to launch and co-market Resonance Health's (ASX:RHT) liver diagnostic, FerriScan in Australia and potentially the UK.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd